Both in Biotechnology
Adaptive Biotechnologies vs CRISPR Therapeutics AG
Over the past year ADPT returned +53.5% and CRSP returned −19.6%; their daily moves had a correlation of 0.36.
ADPT +53.5% CRSP −19.6%Growth of $1, one year, split-adjusted
| Metric | ADPT | CRSP |
|---|---|---|
| Price | $26.64 | $51.42 |
| Market cap | $4.25B | $4.97B |
| Today | −5.43% | −5.23% |
| 1 month | −2.7% | −7.3% |
| 6 months | +86.7% | −0.4% |
| Year to date | +64.0% | −1.9% |
| 1 year | +58.6% | −17.8% |
| Revenue growth (YoY) | +21.5% | +1041.4% |
| Gross margin | 71.8% | 100.0% |
| Net margin | −55.6% | −895.3% |
| P/E (TTM) | — | — |
| Price / sales | 13.8× | 371.3× |
| Net cash | $9.4M | $1.78B |
| Dividend yield | — | — |
| Volatility (60d) | 50.5% | 53.4% |
| Short % of float | 10.0% | 21.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).